Transparency Initiative to provide more information on FDA regulation and drug development

被引：0
|
作者：
Wechsler, Jill
机构：
来源：
FORMULARY | 2010年 / 45卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：232 / 233
页数：2
相关论文
共 50 条
  • [41] The FDA centennial and the drug information association
    Hamrell, Michael R.
    DRUG INFORMATION JOURNAL, 2006, 40 (02): : XIX - XX
  • [42] Industry crisis: calls for more transparency and regulation
    Dorey, E
    CHEMISTRY & INDUSTRY, 2004, (23) : 4 - 4
  • [43] FDA AND NEW DRUG DEVELOPMENT
    JAROWSKI, CI
    DRUG & COSMETIC INDUSTRY, 1971, 108 (01): : 32 - &
  • [44] The Case for Less, Not More, US FDA Regulation
    Vernon, John A.
    Golec, Joseph H.
    PHARMACOECONOMICS, 2011, 29 (08) : 637 - 640
  • [45] The FDA and IBS Drug Development
    Mangel, Allen W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (12): : 3106 - 3106
  • [46] The Case for Less, Not More, US FDA Regulation
    John A. Vernon
    Joseph H. Golec
    PharmacoEconomics, 2011, 29 : 637 - 640
  • [47] FDA Drug Safety Podcasts: Resources for drug information
    Wu, Kimberly
    Shepherd, Jennifer
    Jackson, Steven
    Chew, Catherine
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2013, 53 (02) : 188 - 192
  • [48] Bringing information on evolving FDA standards to bear on ongoing drug development programs
    Versteegh, LR
    Tracey, LM
    DRUG INFORMATION JOURNAL, 1999, 33 (03): : 955 - 963
  • [49] FDA insists on more women in drug trials
    Josefson, D
    BRITISH MEDICAL JOURNAL, 1997, 315 (7112): : 833 - 833
  • [50] Bringing Information on Evolving FDA Standards to Bear on Ongoing Drug Development Programs
    Larry R. Versteegh
    Lynne M. Tracey
    Drug information journal : DIJ / Drug Information Association, 1999, 33 (3): : 955 - 963
12345